SHARE TEXT
 
Nasia Safdar, MD close
9zAGm11VBAE
Nasia Safdar, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Nasia Safdar, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Nasia Safdar has been the Medical Director of Infection Control at UW Hospital and Clinics since 2009. She came to Wisconsin in 1997 for her residency and fellowship. She is board certified in infectious disease and she focuses on healthcare-associated infections, particularly in the acute care setting. Dr. Safdar believes that many health care-associated infections can be prevented with adherence to known best practices. As medical director for the department of infection prevention, her job is to lead the department in its mission of reducing healthcare-associated infections by identifying, testing and implementing interventions that have benefit for reducing health care associated infections (HAI).

 

She is an associate professor of infectious diseases at the University of Wisconsin School of Medicine and Public Health and the Associate Chief of Staff for Research at the William S. Middleton VA Hospital. Her research includes the evaluation of novel and innovative strategies for prevention of HAI. She is currently leading the fecal bacteriotherapy program at UW Hospital and is the principal investigator of a current ongoing VA-funded trial of probiotics for reducing HAI.

Specialties

Infectious Diseases

Clinics

University Hospital
(608) 263-0946 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship Sir Ganga Ram Hospital, Lahore, Pakistan
Medical School Aga Khan University Medical College, Karachi, Pakistan

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Safdar is interested in examining the efficacy of novel interventions to reduce healthcare-associated infection such as the use of probiotics for reducing colonization by methicillin-resistant Staphylococcus aureus and Clostridium difficileand has ongoing trials in this area. 


PubMed Articles
Misch EA Safdar N Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population. Infect Dis Clin North Am . 2019 Jun;33(2):447-466
[PubMed ID: 31005136]
Musuuza JS Guru PK O'Horo JC Bongiorno CM Korobkin MA Gangnon RE Safdar N The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysis. BMC Infect Dis . 2019 May 14;19(1):416
[PubMed ID: 31088521]
Baubie K Shaughnessy C Kostiuk L Varsha Joseph M Safdar N Singh SK Siraj D Sethi A Keating J Evaluating antibiotic stewardship in a tertiary care hospital in Kerala, India: a qualitative interview study. BMJ Open . 2019 May 14;9(5):e026193
[PubMed ID: 31092653]
Barker AK Cowley ES McKinley L Wright MO Safdar N An in-room observation study of hand hygiene and contact precaution compliance for Clostridioides difficile patients. Am J Infect Control . 2019 May 4;
[PubMed ID: 31060870]
Dantes RB Abbo LM Anderson D Hall L Han JH Harris AD Leekha S Milstone AM Morgan DJ Safdar N Schweizer ML Sengupta S Seo SK Rock C Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Infect Control Hosp Epidemiol . 2019 May;40(5):536-540
[PubMed ID: 30932802]
Jorgenson MR Descourouez JL Yang DY Leverson GE Saddler CM Smith JA Safdar N Mandlebrot DA Redfield RR Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients. Ann Pharmacother . 2019 Apr 21;:1060028019845003
[PubMed ID: 31007034]
Mora Pinzon MC Buie R Liou JI Shirley DK Evans CT Ramanathan S Poggensee L Safdar N Outcomes of Community and Healthcare-onset Clostridium difficile Infections. Clin Infect Dis . 2019 Apr 8;68(8):1343-1350
[PubMed ID: 30668844]
Shea G Smith W Koffarnus K Knobloch MJ Safdar N Kamishibai cards to sustain evidence-based practices to reduce healthcare-associated infections. Am J Infect Control . 2019 Apr;47(4):358-365
[PubMed ID: 30522838]
Fitzpatrick MA Suda KJ Ramanathan S Guihan M Brown C Safdar N Evans M Jones MM Pfeiffer CD Klutts JS Icardi M Perencevich E Rubin M Evans CT QUERI CARRIAGE Program. Laboratory practices for identification and reporting of carbapenem-resistant Enterobacteriaceae in Department of Veterans Affairs facilities. Infect Control Hosp Epidemiol . 2019 Apr;40(4):463-466
[PubMed ID: 30829187]
Kates AE Zimbric ML Mitchell K Skarlupka J Safdar N The impact of chlorhexidine gluconate on the skin microbiota of children and adults: A pilot study. Am J Infect Control . 2019 Mar 15;
[PubMed ID: 30879799]
Knobloch MJ Thomas KV Musuuza J Safdar N Exploring leadership within a systems approach to reduce health care-associated infections: A scoping review of one work system model. Am J Infect Control . 2019 Feb 12;
[PubMed ID: 30765147]
Baubie K Shaughnessy C Safdar N Exploring patient perceptions of contact precautions. Am J Infect Control . 2019 Feb;47(2):225-226
[PubMed ID: 30471977]
Brys N Keating JA Knobloch MJ Safdar N Engaging patients in health care epidemiology research: A case example. Am J Infect Control . 2019 Feb;47(2):139-143
[PubMed ID: 30314749]
Cheng YW Phelps E Ganapini V Khan N Ouyang F Xu H Khanna S Tariq R Friedman-Moraco RJ Woodworth MH Dhere T Kraft CS Kao D Smith J Le L El-Nachef N Kaur N Kowsika S Ehrlich A Smith M Safdar N Misch EA Allegretti JR Flynn A Kassam Z Sharfuddin A Vuppalanchi R Fischer M Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant . 2019 Feb;19(2):501-511
[PubMed ID: 30085388]
Pop-Vicas A Johnson S Safdar N Cefazolin as surgical antimicrobial prophylaxis in hysterectomy: A systematic review and meta-analysis of randomized controlled trials. Infect Control Hosp Epidemiol . 2019 Feb;40(2):142-149
[PubMed ID: 30516122]
Craemer KA Sampene E Safdar N Antony KM Wautlet CK Nutrition and Exercise Strategies to Prevent Excessive Pregnancy Weight Gain: A Meta-analysis. AJP Rep . 2019 Jan;9(1):e92-e120
[PubMed ID: 31041118]
Caya T Knobloch MJ Musuuza J Wilhelmson E Safdar N Patient perceptions of chlorhexidine bathing: A pilot study using the health belief model. Am J Infect Control . 2019 Jan;47(1):18-22
[PubMed ID: 30174255]
Richards KA Cesario S Best SL Deeren SM Bushman W Safdar N Reflex urine culture testing in an ambulatory urology clinic: Implications for antibiotic stewardship in urology. Int J Urol . 2019 Jan;26(1):69-74
[PubMed ID: 30221416]
Plafkin C Singh T Astor BC Parajuli S Bhutani G Safdar N Panzer SE Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes. Transpl Infect Dis . 2018 Dec;20(6):e12974
[PubMed ID: 30102820]
Beck AP Baubie K Knobloch MJ Safdar N Promoting Antimicrobial Stewardship by Incorporating it in Undergraduate Medical Education Curricula. WMJ . 2018 Dec;117(5):224-228
[PubMed ID: 30674101]